Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Kanda

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|October 14, 2022
Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell CarcinomaToshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|March 11, 2021
Nutrition and Atopic DermatitisNaoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
Biochemical Pharmacology|November 21, 2009
Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytesNaoko Kanda, Takeko Ishikawa, Shinichi Watanabe
The Journal of Allergy and Clinical Immunology|December 4, 2004
Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytesNaoko Kanda, Hiroshi Mitsui, Shinichi Watanabe
The Journal of Allergy and Clinical Immunology|November 9, 2005
IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytesNaoko Kanda, Satsuki Koike, Shinichi Watanabe
The Journal of Dermatology|June 19, 2023
Two cases of generalized pustular psoriasis successfully treated with bimekizumabTeppei Hagino, Hidehisa Saeki, Naoko Kanda
Journal of Clinical Medicine|September 10, 2021
The Defect in Regulatory T Cells in Psoriasis and Therapeutic ApproachesNaoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2005
Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytesNaoko Kanda, Satsuki Koike, Shinichi Watanabe
Journal of Clinical Medicine|February 11, 2023
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with PsoriasisTeppei Hagino, Hidehisa Saeki, Naoko Kanda
The Journal of Dermatology|August 20, 2022
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in JapanTeppei Hagino, Hidehisa Saeki, Naoko Kanda
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|October 14, 2022
Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell CarcinomaToshihiko Hoashi, Naoko Kanda, Hidehisa Saeki
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|March 11, 2021
Nutrition and Atopic DermatitisNaoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
Biochemical Pharmacology|November 21, 2009
Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytesNaoko Kanda, Takeko Ishikawa, Shinichi Watanabe
The Journal of Allergy and Clinical Immunology|December 4, 2004
Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytesNaoko Kanda, Hiroshi Mitsui, Shinichi Watanabe
The Journal of Allergy and Clinical Immunology|November 9, 2005
IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytesNaoko Kanda, Satsuki Koike, Shinichi Watanabe
The Journal of Dermatology|June 19, 2023
Two cases of generalized pustular psoriasis successfully treated with bimekizumabTeppei Hagino, Hidehisa Saeki, Naoko Kanda
Journal of Clinical Medicine|September 10, 2021
The Defect in Regulatory T Cells in Psoriasis and Therapeutic ApproachesNaoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2005
Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytesNaoko Kanda, Satsuki Koike, Shinichi Watanabe
Journal of Clinical Medicine|February 11, 2023
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with PsoriasisTeppei Hagino, Hidehisa Saeki, Naoko Kanda
The Journal of Dermatology|August 20, 2022
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in JapanTeppei Hagino, Hidehisa Saeki, Naoko Kanda
Pageof 19